UnitedHealth (NYSE: UNH) stock price forecast 2026: Earnings beat, shares target
UnitedHealth (UNH) reported Q3 2026 adjusted EPS of $4.69, beating estimates and raising its full-year guidance to at least $20.50. Revenue was $112.69 bn, slightly down YoY. The medical care ratio improved to 88.4%. Analysts' average price target is $480.60, suggesting 25% upside. Management hinted at 2027 earnings growth exceeding expectations.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for earnings growth, supporting a bullish stance on UNH.
Market read
UNH's strong earnings and guidance upgrade are likely to drive buying interest and influence the health‑care sector.
What to watch
Potential headwinds from Medicare Advantage cost pressures and declining membership may limit upside.
Background
UnitedHealth Group reported Q3 2026 results, beating consensus and raising its FY EPS outlook, with a lower medical cost ratio.
Ticker impact
Q3 2026 earnings beat and raised full-year adjusted EPS guidance to at least $20.50, the first report of these numbers.
likely upward pressure as investors price in the earnings beat and raised guidance
The beat was sizable and the guidance increase is material for a large‑cap health insurer, driving fresh buying interest.
Market effects
Improved profitability may lift other health‑insurance peers and related healthcare services.
U.S. market likely to see a modest rally in the health‑care sector.
Signals resilience in U.S. managed‑care business, relevant for global insurers tracking U.S. trends.
Counterpoint
If medical cost ratio improvements rely heavily on reserve releases, future earnings could be volatile.
Key entities
- companyUnitedHealth Group
Largest U.S. private health insurer
